The Headline That Lit The Match

Earlier this month, passengers aboard the MV Hondius started getting sick while crossing the Atlantic.

Health officials later identified suspected cases tied to the Andes strain of hantavirus. A few deaths were reported. Two Americans were transported in biocontainment units.

The setup looked familiar.

COVID permanently rewired how markets react to health scares.

Back in 2020, the biggest money was made when vaccine names started ripping before the rest of Wall Street fully understood what was happening.

So now, every time a virus story hits the tape, traders immediately ask the same question:

“Which stock moves first if this becomes bigger?”

That reflex kicked in almost instantly last week.

Here’s the story ⇩

SPONSOR BREAK presented by BanyanHill*

44 Trillion “Super Convergence”: Elon’s Biggest Move EVER? 
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon’s top lobbyists…  Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it’s just the start of an Elon Musk $44 trillion “Superconvergence…” An event that could kick off as soon as June 9th.
Click here now to watch hall of fame trader Jon Najarian’s full prediction.

First — what is hantavirus? 🦠

Earlier this month, passengers aboard the MV Hondius — a cruise ship crossing the Atlantic — started getting sick.

Health officials identified seven cases of the Andes strain of hantavirus. Three people died. Seventeen American passengers were repatriated, two of them in biocontainment units.

Hantavirus in plain English: Hantaviruses are a family of viruses spread primarily by rodents. Most strains cannot pass between people at all. The Andes strain — found mainly in Argentina and Chile — is one of the rare exceptions where limited human-to-human transmission has been documented.

The WHO, CDC, and every major health organization said the same thing:
→ this is not another COVID.
→ It does not spread through the air.
→ It requires close, prolonged physical contact.
→ The total number of confirmed cases on the ship was seven.

That did not stop the market from reacting like it might be. ⇩

SPONSOR BREAK presented by BrownstoneResearch*

Millionaire warns: “Move your money now.”
Larry Benedict generated $274 million in profits for his clients by knowing where money flows when the Federal Reserve shifts.

He says Trump’s Fed Takeover is triggering the most significant shift in U.S. markets in nearly 20 years.

He’s already identified the one ticker he expects billions to flood into… and he’s giving away the name for free.

Click here to get the full details before the window closes.

The stocks — one by one

1 Moderna MRNA ( ▼ 0.77% ) – The most connected play
→ +12% Fri – May 8
→ +8% Mon AM – May 11
→ -3.6% Mon PM – May 11

Moderna is the only company in this group with a documented, active connection to hantavirus research. It disclosed that it has been conducting preclinical research on hantaviruses in collaboration with the US Army Medical Research Institute of Infectious Diseases and the Vaccine Innovation Center at Korea University — research that predates the outbreak entirely.

Moderna also lists both “Hantaan virus” and “Hantaviruses causing Hanta Pulmonary Syndrome” as permitted pathogens on its mRNA Access program, which lets researchers use its technology to develop vaccines. The mRNA platform that powered its COVID vaccine is theoretically adaptable to new pathogens quickly.

That is the real bull case here — not this specific outbreak, but the platform’s ability to respond to whatever comes next.

The reality check: analysts at Evercore ISI were blunt. “Hantavirus is a low-incidence, structurally small market. We see no meaningful revenue opportunity.”

Even if Moderna fast-tracked a vaccine, the total addressable market is a fraction of a fraction of what COVID represented.

→ Moderna sold $18.4 billion in vaccines in 2021. A hantavirus vaccine would not move that needle.

● Connection: Real — but revenue opportunity is minimal.

SPONSOR BREAK presented by MarketWise*

Massive 512,000-Line Data Leak Exposes Shocking AI Breakthrough
60-year Wall Street veteran and financial technology pioneer Marc Chaikin recently reviewed a massive data leak inside one of the world’s biggest AI labs. He discovered a hidden mechanism in the code that could create extraordinary wealth for savvy investors – and inflict grave financial hardships on everyone else. Click here for the full story.

2 Inovio Pharmaceuticals INO ( ▲ 1.49% ) – The 2011 grant story
Spiked premarket → -3.1% by close

Inovio’s connection to hantavirus is real — but old.

In 2011, the company received a US Defense Department grant to develop a device for delivering DNA vaccines, intended for testing against the Hantaan virus and other pathogens.

In 2015, several Inovio employees co-authored a paper evaluating the device’s efficacy, concluding it was a low-cost tool for rapid mass vaccination. Sounds promising.

The catch: that was 2015. Inovio has never produced a commercial product from this research — not a vaccine, not a treatment, not a single approved product tied to hantavirus.

The stock moved on a fifteen-year-old grant and a paper that never became a product.

● Connection: Technically real — commercially nonexistent.

3 Novavax NVAX ( ▲ 1.3% ) – The COVID association play
Spiked premarket → -5.4% by close

Novavax has no active hantavirus program. No research. No grants. No pipeline.

It moved purely because it was a COVID-era standout — the sole provider of an approved non-mRNA vaccine during the pandemic.

The market saw “health scare” and bought the last vaccine company it remembered winning.

By Monday afternoon, investors appeared to remember that association is not the same as relevance. Novavax gave back more than anyone else in the group.

● Connection: None — purely a COVID memory trade.

SPONSOR BREAK presented by Paradigm*

Altucher: This is My Favorite FREE Starlink Pre-IPO Ticker
Legendary investor James Altucher just gave out one of his TOP stock picks for the coming Starlink IPO – 100% FREE.
 
Usually he holds these plays “close to the vest”…
 
But with Starlink going public as soon as June 9th…
 
NOW is the time to act.
 
You can watch James’ latest video for yourself, right here.
 
It’s a brief, 3-minute video, and reveals the name and ticker symbol for FREE.
 Click here to check it out now.

4 QuidelOrtho QDEL ( ▲ 3.08% )– The diagnostic play

Moved on diagnostic testing demand thesis

QuidelOrtho makes diagnostic testing equipment — the kind used to identify viruses quickly in clinical settings.

The thesis here is straightforward: if hantavirus spreads, demand for rapid diagnostic tests goes up, and QuidelOrtho is positioned to supply them. A reasonable logic chain, but one that requires a scale of outbreak that health officials say is extremely unlikely to materialize.

● Connection: Logical — but depends on an outbreak that experts say will not happen.

5 3M MMM ( ▼ 1.35% ) – The N95 play

Moved on PPE demand thesis

3M is one of the world’s largest suppliers of N95 respirator masks that became impossible to find in early 2020.

The hantavirus trade swept it up on the same PPE demand logic that drove mask manufacturers during COVID.

Like QuidelOrtho, the connection is real but contingent on a scale of outbreak that the evidence does not currently support.

● Connection: Real product — wrong scale of outbreak.

5 Carnival, Royal Caribbean & cruise stocks – The obvious losers

Declined on outbreak news

While biotech stocks spiked, cruise lines moved in the opposite direction — the most intuitive trade of the whole episode.

A virus originating on a cruise ship is bad for cruise ship bookings. The broader concern is that fearful travelers may get cold feet about upcoming trips.

However, analysts noted that cruise lines are already facing a much bigger headwind from spiking energy prices driven by the Iran war. Hantavirus added noise to an already difficult backdrop.

● Connection: Direct — but energy costs are the bigger problem

The Pattern:

What happened last week is not unusual.

Fear arrives faster than analysis. By the time the analysis catches up, the trade has already run.

The stocks that move most in these moments are not always the ones with the strongest connection to the actual event. They are the ones the market most strongly associates with the last time something similar happened.

The honest takeaway from last week is about how fear trades work — and how quickly the market corrects itself when the facts do not match the fear.

Lesson Of The Day:

Was this email forwarded to you? Don’t miss out on future stories — subscribe using the button below.

Also, help your friends blossom this spring! Share us with them.

💬 We Want To Hear Your Story:

Got a market or stock you want us to analyze next?

Just drop your request in the comments here.

P.S. – If you no longer want to receive occasional emails from us and you want to unsubscribe, click here 👉 “Unsubscribe” . Thank you!